In vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 2, 2011, Pages 767-774

  Suzuki, Takashi ^a   Swoboda, Jonathan G ^a   Campbell, Jennifer ^a   Walker, Suzanne ^a   Gilmore, Michael S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1835F03; ANTIBIOTIC AGENT; CIPROFLOXACIN; GENTAMICIN; METICILLIN; TARGOCIL; TEICHOIC ACID; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC BIOSYNTHESIS; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONTROLLED STUDY; CORNEA CELL; CYTOTOXICITY; DRUG EFFICACY; DRUG EXPOSURE; DRUG INHIBITION; DRUG POTENTIATION; HUMAN; HUMAN CELL; KERATITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; CORNEA; EPITHELIAL CELLS; HUMANS; KERATITIS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP; TEICHOIC ACIDS;

EID: 78751687332     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00879-10     Document Type: Article

References (42)

1. Alexandrakis, G., E. C. Alfonso, and D. Miller. 2000. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 107:1497-1502.
2. Andersson, D. I., and B. R. Levin. 1999. The biological cost of antibiotic resistance. Curr. Opin. Microbiol. 2:489-493.
3. Barcia-Macay, M., C. Seral, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke. 2006. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob. Agents Chemother. 50:841-851.
4. Bourcier, T., F. Thomas, V. Borderie, C. Chaumeil, and L. Laroche. 2003. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br. J. Ophthalmol. 87:834-838.
5. Campbell, J., et al. 2010. Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem. Biol. [Epub ahead of print.] doi:10.1021/cb100269f.
6. Centers for Disease Control and Prevention. 1999. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. MMWR Morb. Mortal. Wkly. Rep. 48:707-710.
7. Chang, S., et al. 2003. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 348:1342-1347.
8. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. CLSI M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Corrigan, R. M., H. Miajlovic, and T. J. Foster. 2009. Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiol. 9:22.
10. Cory, A. H., T. C. Owen, J. A. Barltrop, and J. G. Cory. 1991. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3:207-212.
11. D'Elia, M. A., et al. 2006. Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway. J. Bacteriol. 188:4183-4189.
12. Duthie, E. S., and L. L. Lorenz. 1952. Staphylococcal coagulase; mode of action and antigenicity. J. Gen. Microbiol. 6:95-107.
13. Foster, T. J., and M. Hook. 1998. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 6:484-488. (Pubitemid 29002881)
14. Freidlin, J., et al. 2007. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am. J. Ophthalmol. 144:313-315.
15. Fridkin, S. K., et al. 2005. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352:1436-1444.
16. Grundling, A., and O. Schneewind. 2006. Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus, J. Bacteriol. 188:2463-2472.
17. Grundmeier, M., et al. 2004. Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function. Infect. Immun. 72:7155-7163.
18. Gualtieri, M., F. Baneres-Roquet, P. Villain-Guillot, M. Pugniere, and J. P. Leonetti. 2009. The antibiotics in the chemical space. Curr. Med. Chem. 16:390-393.
19. Iihara, H., et al. 2006. Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections. Diagn. Microbiol. Infect. Dis. 56:297-303.
20. Jett, B. D., and M. S. Gilmore. 2002. Internalization of Staphylococcus aureus by human corneal epithelial cells: role of bacterial fibronectin-binding protein and host cell factors. Infect. Immun. 70:4697-4700.
21. Key, J. E. 2007. Development of contact lenses and their worldwide use. Eye Contact Lens 33:343-345.
22. Kohler, T., C. Weidenmaier, and A. Peschel. 2009. Wall teichoic acid protects Staphylococcus aureus against antimicrobial fatty acids from human skin. J. Bacteriol. 191:4482-4484.
23. Kreiswirth, B. N., et al. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:709-712.
24. Lee, K., J. Campbell, J. G. Swoboda, G. D. Cuny, and S. Walker. 2010. Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus. Bioorg. Med. Chem. Lett. 20:1767-1770.
25. Liang, X., and Y. Ji. 2007. Comparative analysis of staphylococcal adhesion and internalization by epithelial cells. Methods Mol. Biol. 391:145-151.
26. Lorian, V. 1996. Antibiotics in laboratory medicine, 4th ed. The Williams & Wilkins Co., Baltimore, MD.
27. Maki, H., T. Yamaguchi, and K. Murakami. 1994. Cloning and characterization of a gene affecting the methicillin resistance level and the autolysis rate in Staphylococcus aureus. J. Bacteriol. 176:4993-5000.
28. Meredith, T. C., J. G. Swoboda, and S. Walker. 2008. Late-stage polyribitol phosphate wall teichoic acid biosynthesis in Staphylococcus aureus. J. Bacteriol. 190:3046-3056.
29. Neuhaus, F. C., and J. Baddiley. 2003. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67:686-723.
30. O'Brien, L. M., E. J. Walsh, R. C. Massey, S. J. Peacock, and T. J. Foster. 2002. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell. Microbiol. 4:759-770.
31. Ohlsen, K., and U. Lorenz. 2007. Novel targets for antibiotics in Staphylococcus aureus. Future Microbiol. 2:655-666.
32. Ormerod, L. D., et al. 1987. Epidemiology of microbial keratitis in southern California. A multivariate analysis. Ophthalmology 94:1322-1333.
33. Peterson, D. L. 1999. Vancomycin-resistant Staphylococcus aureus. Infect. Med. 16:235-238.
34. Shiratsuchi, A., et al. 2010. Auxiliary role for D-alanylated wall teichoic acid in Toll-like receptor 2-mediated survival of Staphylococcus aureus in macrophages. Immunology 129:268-277.
35. Sievert, D. M., et al. 2008. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin. Infect. Dis. 46:668-674.
36. Swoboda, J. G., J. Campbell, T. C. Meredith, and S. Walker. 2010. Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem 11:35-45.
37. Swoboda, J. G., et al. 2009. Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus. ACS Chem. Biol. 4:875-883.
38. Tenover, F. C., and R. V. Goering. 2009. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J. Antimicrob. Chemother. 64:441-446.
39. Weidenmaier, C., et al. 2004. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med. 10:243-245.
40. Weidenmaier, C., et al. 2008. Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int. J. Med. Microbiol. 298:505-513.
41. Weidenmaier, C., and A. Peschel. 2008. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat. Rev. Microbiol. 6:276-287.
42. Weidenmaier, C., et al. 2005. Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J. Infect. Dis. 191:1771-1777.